about
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinomaClinical characteristics of second primary pancreatic cancer.Clinical characteristics of long-term survivors of inoperable pancreatic cancer: an 8-year cohort analysis in Korea.Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts.High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study.Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Behçet's disease.Gastrojejunostomy by pure natural orifice transluminal endoscopic surgery using a newly designed anastomosing metal stent in a porcine model.Best options for preoperative biliary drainage in patients with Klatskin tumors.Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer.Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer.Transition zone defect associated with the response to proton pump inhibitor treatment in patients with globus sensation.Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancerIdentification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAsNovel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient OutcomeVIPoma that arose from the rectum in a 65-year-old male patientEfficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort studyKML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective studyPreoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinomaA novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study
P50
Q33696404-01559F0D-6964-4514-90E6-A7B4F471B41FQ33834675-88B1A21E-731C-412F-987E-42A3444EEA35Q39165364-55FA6602-A1C6-49B2-AA32-AB7C3A5FB08CQ39551266-840D91CB-9EB0-4F88-9D43-3A709CCC7EA7Q46925560-E7F16BCC-362D-453B-8A08-D07F917570BAQ47847106-187A9A67-AB1A-460A-9B46-225D4C410DEAQ47930141-BD6ADDA4-2A51-4877-AC4B-75E0FBCD52AEQ50799518-1DDA0CD5-A8DF-419C-839E-A031E42C4A08Q51799569-2D7D4C8E-B202-4BA9-8F47-D1269001D55FQ53071911-BB2E7FFE-06FA-4228-8215-A013F483F8D0Q53340280-52FC0F17-2F0D-454D-8C8C-A0D25FB9C771Q59328908-ECA98000-ADAE-4290-91F3-95AA7899B825Q64053093-CF6258D8-BC8D-4836-A141-BC23D5EF1C6BQ64275704-C033D4A9-1D9F-4613-AA7B-BEB47A636B82Q83476159-3BC80860-D641-4CE9-BC0F-210473065769Q89216394-4CF464AE-CD9B-41EE-B8DE-84DEA1279F4EQ90908991-07A8DA25-7CE8-4ED0-B201-F24D2D035AD4Q92698374-8EB5BC6D-FF05-4AC5-86EE-4C1DDA053D9AQ93099517-FB3B292A-E1BD-4F4F-B5D9-765CB4B84254
P50
description
researcher ORCID ID = 0000-0002-2641-8873
@en
wetenschapper
@nl
name
Jung Hyun Jo
@ast
Jung Hyun Jo
@en
Jung Hyun Jo
@nl
type
label
Jung Hyun Jo
@ast
Jung Hyun Jo
@en
Jung Hyun Jo
@nl
prefLabel
Jung Hyun Jo
@ast
Jung Hyun Jo
@en
Jung Hyun Jo
@nl
P106
P31
P496
0000-0002-2641-8873